Clinical Research Directory
Browse clinical research sites, groups, and studies.
Genome Environment Microbiome and Metabolome in Autism Study
Sponsor: Massachusetts General Hospital
Summary
GEMMA is a multicenter longitudinal observational study that follows children who are genetically at-risk of developing autism for their first three years of life, seeking to identify potential biomarkers predictive of autism development in the blood, stool, urine and saliva. The biomarkers identified in this project will contribute to a better understanding of the pathogenesis of ASD in at-risk children and possible solutions for alleviating and/or preventing ASD and ASD-related symptoms in patients in the future.
Official title: Genome Environment Microbiome and Metabolome in Autism
Key Details
Gender
All
Age Range
Any - 6 Months
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2019-07-01
Completion Date
2025-12-31
Last Updated
2025-12-24
Healthy Volunteers
Not specified
Conditions
Locations (3)
Massachusetts General Hospital for Children
Boston, Massachusetts, United States
National University of Ireland Galway
Galway, Ireland
The Azienda Sanitaria Locale Salerno
Salerno, Italy